£65-75k
Medical devices that enable treatment from cancer patients' homes
Job no longer available
Medical devices that enable treatment from cancer patients' homes
21-100 employees
Job no longer available
£65-75k
21-100 employees
To build solutions that give cancer patients more quality time than any alternative.
Jump to section
To build solutions that give cancer patients more quality time than any alternative.
Entia have developed a hand-held blood testing kit that can be used at home by chemotherapy patients to tailor treatment to their specific needs.
Its monitor can reduce cancellations for chemotherapy appointments and limit hospital visits just for blood count checks. And that means there are more chemotherapy slots for other people awaiting urgent treatment.
Using the monitor not only ensures that clinical pathways are fashioned around the individual’s needs but it also achieves a significant reduction in healthcare spending.
After forming a partnership with Pfizer UK and using some of its latest funding on creating Entia Liberty - the virtual oncology solution, the company is focused on offering virtual monitoring service being made available in the UK for metastatic breast cancer patients, pending the usual regulatory approval.
Freddie
Company Specialist
Jul 2023
$21.1m
SERIES A
Oct 2021
$12m
EARLY VC
This company has top investors
Founders
Toby Basey-Fisher
(CEO)Previously Enterprise Fellow at Imperial College London.
Joined as an Engineer, promoted to Head of Innovation after 20 months, then again to CTO after 7 months.